Dong Shen, Ph.D.
Affiliations: | 2009 | Johns Hopkins University, Baltimore, MD |
Area:
Genetics, OncologyGoogle:
"Dong Shen"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Bert Vogelstein | grad student | 2009 | Johns Hopkins | |
| (Genome-wide approaches to study genetic alterations in gene families and on human chromosome 8p.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhu J, Liu Z, Liang X, et al. (2022) A Pan-Cancer Study of KMT2 Family as Therapeutic Targets in Cancer. Journal of Oncology. 2022: 3982226 |
| Shen D, Zhang J, Yuan K, et al. (2021) Landscape of IDH1/2 mutations in Chinese patients with solid tumors: A pan-cancer analysis. Molecular Genetics & Genomic Medicine. e1697 |
| He SY, Lin QF, Chen J, et al. (2021) Efficacy of afatinib in a patient with rare EGFR (G724S/R776H) mutations and amplification in lung adenocarcinoma: A case report. World Journal of Clinical Cases. 9: 1329-1335 |
| Chen C, Shen D, Li J, et al. (2018) TTF-1 and EGFR expression are related to EGFR mutation in lung adenocarcinoma. International Journal of Clinical and Experimental Pathology. 11: 4650-4656 |
| Miller CA, Gindin Y, Lu C, et al. (2016) Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers. Nature Communications. 7: 12498 |
| Jiang L, Huang J, Higgs BW, et al. (2016) Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer. Plos Genetics. 12: e1005895 |
| Churpek JE, Pyrtel K, Kanchi KL, et al. (2015) Genomic analysis of germline and somatic variants in familial myelodysplasia/acute myeloid leukemia. Blood |
| Klco JM, Miller CA, Griffith M, et al. (2015) Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia. Jama. 314: 811-22 |
| Wong TN, Ramsingh G, Young AL, et al. (2015) Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia. Nature. 518: 552-5 |
| Klco JM, Miller CA, Griffith M, et al. (2015) Abstract PR11: Genomic approaches for risk assessment in acute myeloid leukemia Cancer Research. 75 |